(MedPage Today) — Outcomes have substantially improved over time in patients with relapsed or refractory classical Hodgkin lymphoma who underwent hematopoietic cell transplantation (HCT), according to a retrospective, registry-based cohort study…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
